Locomotor behaviors in response to new selective D-1 and D-2 dopamine receptor agonists, and the influence of selective antagonists

Pharmacology, Biochemistry and Behavior

Volumn 25, Issue 1, 1986, Pages 249-253

  Molloy, Anthony G ^a   O'Boyle, Kathy M ^a   Pugh, Mark T ^a   Waddington, John L ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Behavior; D 1 dopamine receptors; D 2 dopamine receptors; Locomotion

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 BROMO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; FLUPENTIXOL; METOCLOPRAMIDE; N (3 HYDROXYPHENETHYL) N (PHENETHYL)PROPYLAMINE; PIFLUTIXOL; PIQUINDONE; RADIOISOTOPE; SPIPERONE;

ANIMAL EXPERIMENT; BEHAVIOR; CENTRAL NERVOUS SYSTEM; DRUG EFFICACY; ENANTIOMER; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MOTOR ACTIVITY; MUSCULOSKELETAL SYSTEM; NONHUMAN; PIFLUTIXOL H 3; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RAT; SPIPERONE H 3; STEREOTYPY;

ANIMAL; BENZAZEPINES; COMPARATIVE STUDY; FLUPENTHIXOL; ISOQUINOLINES; MALE; METOCLOPRAMIDE; MOTOR ACTIVITY; PHENETHYLAMINES; RATS; RATS, INBRED STRAINS; RECEPTORS, DOPAMINE; SCH-23390; SK&F-38393; STIMULATION, CHEMICAL; SUPPORT, NON-U.S. GOV'T;

EID: 0022533980     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(86)90262-5     Document Type: Article

References (39)

1. The role of dopamine in locomotor activity and learning
2. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors
3. Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics
4. The classification of dopamine receptors: relationship to radioligand binding
5. Preferential inhibition of ligand binding to calf striatal dopamine D-1 receptors by SCH 23390
6. Pharmacological effects of Ro 22-1319: a new antipsychotic agent
7. Activity of two new potent dopaminergic agonists at the striatal and anterior pituitary levels
8. The relative importance of dopamine and norepinephrine in mediating locomotor activity
9. An observational method for quantifying behavioural effects of dopamine agonists: contrasting effects of d-amphetamine and apomorphine
10. SCH 23390: the first selective dopamine D-1 antagonist
11. Functional evidence for selective dopamine D-1 receptor blockade by SCH 23390
12. SCH 23390 a potential benzazepine antipsychotic with unique interactions on dopaminergic systems
13. Neural substrates mediating amphetamine responses
14. Absolute stereochemistry and dopaminergic activity of enantiomers of 2,3,4,5 - tetrahydro - 7,8 - dihydroxy - 1 - phenyl - 1H - 3 benzazepine
15. Multiple receptors for dopamine
16. Dopamine-sensitive adenylate cyclase as a receptor site
17. Dopamine receptors re-explained
18. A computer-supported method for analysing behavioural observations: studies with stereotypy
19. Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: evidence for two different mechanisms of action
20. SCH 23390: a selective D-1 dopamine antagonist with potent D-2 behavioral actions
21. Dopaminergic behaviour stereospecifically promoted by the D-1 agonist R-SK&F 38393 and selectively blocked by the D-1 antagonist SCH 23390
22. Sniffing, rearing and locomotor responses to the D-1 dopamine agonist R-SK&F 38393 and to apomorphine: differential interactions with the selective D-1 and D-2 antagonists SCH 23390 and metoclopramide
23. The enantiomers of SK& 83566, a new selective D-1 dopamine receptor antagonist, stereospecifically block stereotyped behaviour induced by apomorphine and by the selective D-2 and agonist RU 24213
24. 3H-spiperone binding to striatal D-1 and D-2 dopamine receptors: comparisons with SCH 23390
25. Identification of the enantiomers of SK&F 83566 as specific and stereoselective antagonists at the striatal D-1 dopamine receptor: comparisons with the D-2 enantioselectivity of Ro 22-1319
26. Structural determinants of selective affinity for brain D-1 dopamine receptors within a series of 1-phenyl-1H-3-benzazepine analogues of SK&F 38393 and SCH 23390
27. Benzazepine derivatives: nature of the selective and stereospecific interactions of SK&F 38393 and SCH 23390 with brain D-1 receptors
28. A dopamine receptor model and its application in the design of a new class of rigid pyrrolo (2,3-g)isoquinoline antipsychotics
29. Effects of the putative D-1 antagonist SCH 23390 on stereotyped behaviour induced by the D-2 agonist RU 24213
30. Critical issues in assessing the behavioural effects of amphetamine
31. A critique of the methods available for the measurement of spontaneous motor activity
32. Behavioural and neurochemical determinants of drug-induced stereotypy
33. New aspects on the role of dopamine, acetylcholine and GABA in the development of tardive dyskinesia
34. Brain dopamine receptors
35. The central effects of a novel dopamine agonist
36. Two dopamine receptors: biochemistry, physiology and pharmacology
37. The morphogenesis of stereotyped behaviour induced by the dopamine receptor agonist apomorphine in the laboratory rat
38. Functional heterogeneity of multiple dopamine receptors during six months treatment with distinct classes of neuroleptic drugs